Price History
Feb 9, 2026 — Apr 4, 2026Investment Snapshot
- Trading 258% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 3/9 — signs of financial weakness
- ROE of 8.5% — below-average profitability
ONTO INNOVATION INC. (ONTO) is a Healthcare company operating in Measuring & Controlling Devices, NEC, listed on the NYSE , with a market capitalisation of $10.4 billion . Key value metrics: P/E ratio 58.1, P/B ratio 4.96, Piotroski F-Score 3 out of 9 .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
ONTO INNOVATION INC. — Fundamental Analysis Summary
ONTO INNOVATION INC. (ONTO) is currently trading 258% above its Graham Number of $58.57, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 58.1x.
On financial health, ONTO shows a weak Piotroski F-Score of 3/9, a signal of deteriorating financial health, and modest return on equity of 8.5% (sector average: -19.8%), and minimal leverage with a debt-to-equity ratio of 0.13.
StockPik's composite Value Score for ONTO is 35/100 — reflecting current market or financial concerns. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
ONTO reports a solid gross margin of 51.7% (sector average: 33.5%) and a solid operating margin of 17.4%.
ONTO shows revenue growing at 2% year-over-year, with earnings declining at 32%.